Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act.
Clicks: 202
ID: 61041
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
68.4
/100
192 views
158 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
lee2019foolannals
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lee, Theodore T;Solomon, Daniel H;Kesselheim, Aaron S; |
| Journal | annals of internal medicine |
| Year | 2019 |
| DOI |
10.7326/M19-1218
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.